Up to 80% of men and 70% of women with MS experience sexual dysfunction — yet fewer than one in five physicians address it ...

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Columnist Ahna Crum, who's a practitioner in functional medicine, questioned herself when she had an unexpected MS relapse.

Researchers at Oregon Health & Science University have identified a gene that plays a crucial role in the brain's ability to ...

Discovery may open the way for new treatments for multiple sclerosis, leukodystrophies OHSU researchers discover a gene that ...